<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title> &#187; osteoporosis</title>
	<atom:link href="http://medicalconsumers.org/tag/osteoporosis/feed/" rel="self" type="application/rss+xml" />
	<link>http://medicalconsumers.org</link>
	<description></description>
	<lastBuildDate>Fri, 03 Feb 2012 21:23:17 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='medicalconsumers.org' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://s2.wp.com/i/buttonw-com.png</url>
		<title> &#187; osteoporosis</title>
		<link>http://medicalconsumers.org</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://medicalconsumers.org/osd.xml" title="" />
	<atom:link rel='hub' href='http://medicalconsumers.org/?pushpress=hub'/>
		<item>
		<title>Warning on bone drugs: stop after 5 years</title>
		<link>http://medicalconsumers.org/2011/09/23/warning-on-bone-drugs-stop-after-5-years/</link>
		<comments>http://medicalconsumers.org/2011/09/23/warning-on-bone-drugs-stop-after-5-years/#comments</comments>
		<pubDate>Fri, 23 Sep 2011 17:07:35 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[Actonel]]></category>
		<category><![CDATA[bisphosphonates]]></category>
		<category><![CDATA[Boniva]]></category>
		<category><![CDATA[drug maker-invented "disease"]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[hip fracture prevention]]></category>
		<category><![CDATA[hip fractures and osteoporosis]]></category>
		<category><![CDATA[osteonecrosis of jaw]]></category>
		<category><![CDATA[osteopenia]]></category>
		<category><![CDATA[osteoporosis drugs]]></category>
		<category><![CDATA[Reclast]]></category>
		<category><![CDATA[spontaneous thighbone fractures]]></category>

		<guid isPermaLink="false">http://medicalconsumers.org/?p=8696</guid>
		<description><![CDATA[First, a trip down memory lane on the use of bone drugs for the prevention of hip fractures. It is now 16 years since Merck’s widely prescribed Fosamax went on the market. In time, it was prescribed inappropriately to women with so-called “pre-osteoporosis” or osteopenia (yet-another drug maker-invented “disease”). It was also prescribed inappropriately to women in their early 50s, thanks to Merck’s marketing strategies that made us think we would start crumbling inside right after menopause. Then came the reports of osteonecrosis of the jaw and spontaneous thighbone fractures in some women on Fosamax. And now, the latest bulletin on Fosamax and its knock-offs like Actonel, Reclast, and Boniva:  If you have been on one of these drugs for five years, stop taking it.<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=8696&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2011/09/23/warning-on-bone-drugs-stop-after-5-years/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
		<item>
		<title>Bone drugs&#8217; adverse effect found to be very rare</title>
		<link>http://medicalconsumers.org/2010/05/28/bone-drug-side-effect-is-very-rare/</link>
		<comments>http://medicalconsumers.org/2010/05/28/bone-drug-side-effect-is-very-rare/#comments</comments>
		<pubDate>Fri, 28 May 2010 17:18:15 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[Pain]]></category>
		<category><![CDATA[Scans and X-rays]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[Actonel]]></category>
		<category><![CDATA[Boniva]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[hip fractures]]></category>
		<category><![CDATA[osteonecrosis of jaw]]></category>
		<category><![CDATA[osteoporosis drugs]]></category>
		<category><![CDATA[Reclast]]></category>
		<category><![CDATA[spontaneous thighbone fractures]]></category>
		<category><![CDATA[Zometa]]></category>

		<guid isPermaLink="false">http://medicalconsumers.org/?p=5393</guid>
		<description><![CDATA[Remember those scary reports of spontaneous thighbone fractures that occurred in some women who were taking fracture-prevention drugs like Fosamax? The bone breaks for no apparent reason. (In one memorable case, a woman said her thighbone broke while standing in a stalled subway train that lurched suddenly.) Such fractures are described as very rare (0.03%), according to a new analysis of the data generated by three large trials. <img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=5393&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2010/05/28/bone-drug-side-effect-is-very-rare/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
		<item>
		<title>Osteoporosis drugs</title>
		<link>http://medicalconsumers.org/2010/03/22/4717/</link>
		<comments>http://medicalconsumers.org/2010/03/22/4717/#comments</comments>
		<pubDate>Mon, 22 Mar 2010 14:33:20 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[Screening]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[bone drugs]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[hip fractures]]></category>
		<category><![CDATA[hip fractures and osteoporosis]]></category>
		<category><![CDATA[osteonecrosis of jaw]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[osteoporosis drugs]]></category>

		<guid isPermaLink="false">http://medicalconsumers.org/?p=4717</guid>
		<description><![CDATA[Older women have long been encouraged to have their bone density measured periodically.  And many who followed the advice have walked away with a prescription for Fosamax. Not incidentally, the promotion of bone density testing has been spearheaded by Merck, maker of Fosamax, which is widely prescribed to women with bone loss. A decade after Fosamax became available in 1995 medical journals began reporting an apparently rare side effect. <img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=4717&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2010/03/22/4717/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
		<item>
		<title>Prevent falls with vitamin D3</title>
		<link>http://medicalconsumers.org/2009/09/23/prevent-falls-with-vitamin-d3/</link>
		<comments>http://medicalconsumers.org/2009/09/23/prevent-falls-with-vitamin-d3/#comments</comments>
		<pubDate>Wed, 23 Sep 2009 13:00:20 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[testing]]></category>
		<category><![CDATA[vitamins]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[bone density]]></category>
		<category><![CDATA[calcium]]></category>
		<category><![CDATA[hip fractures]]></category>
		<category><![CDATA[prevent falls]]></category>
		<category><![CDATA[vitamin d deficiency]]></category>
		<category><![CDATA[vitamin D3]]></category>

		<guid isPermaLink="false">http://medicalconsumers.org/?p=3204</guid>
		<description><![CDATA[“Vitamin D increases the uptake of calcium. If one has more vitamin D, [the] calcium uptake is more efficient and less calcium may be sufficient.  That does not mean that we do not need calcium -- calcium is important for bone -- but it means that when we get sufficient vitamin D, we may lower the recommendations for calcium intake. In clinical practice this may offer the opportunity to recommend vitamin D supplementation in combination with a ‘bone healthy diet’ covering calcium needs by milk products and vegetable rich in calcium. This is possible if the target intake of calcium is 700 mg of calcium per day rather than 1000 to 1500 mg per day.” <img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=3204&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2009/09/23/prevent-falls-with-vitamin-d3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
		<item>
		<title>The Marketing of Osteoporosis</title>
		<link>http://medicalconsumers.org/2009/05/19/the-marketing-of-osteoporosis/</link>
		<comments>http://medicalconsumers.org/2009/05/19/the-marketing-of-osteoporosis/#comments</comments>
		<pubDate>Tue, 19 May 2009 19:22:21 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[Drug ads]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[Scans and X-rays]]></category>
		<category><![CDATA[Screening]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[Fosamax]]></category>

		<guid isPermaLink="false">http://medconsumers.wordpress.com/?p=2210</guid>
		<description><![CDATA[How a risk factor (bone loss) became a disease (osteoporosis) by Maryann Napoli. Originally published in American Journal of Nursing, May 2009 Nurses probably get the same question I often get as a consumer advocate.  Should I be on this drug? You’re asked because you’re seen as the expert or simply a knowledgeable friend.  In fact, [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=2210&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2009/05/19/the-marketing-of-osteoporosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
	</channel>
</rss>
